Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

被引:36
作者
Goldschmidt, H
Sonneveld, P
Cremer, FW
van der Holt, B
Westveer, P
Breitkreutz, I
Benner, A
Glasmacher, A
Schmidt-Wolf, IGD
Martin, H
Hoelzer, D
Ho, AD
Lokhorst, HM
机构
[1] Univ Heidelberg, Med Klin & Poliklin 5, D-69115 Heidelberg, Germany
[2] Univ Rotterdam Hosp, Dept Hematol, NL-3015 GD Rotterdam, Netherlands
[3] Univ Rotterdam Hosp, HOVON Data Ctr, NL-3015 GD Rotterdam, Netherlands
[4] Deutsch Krebsforschungszentrum, Zent Einheit Biostat, D-69120 Heidelberg, Germany
[5] Univ Bonn, Med Klin & Poliklin 1, D-53105 Bonn, Germany
[6] Univ Klin Frankfurt, Med Klin 3, D-60596 Frankfurt, Germany
[7] Univ Utrecht Hosp, Dept Hematol, NL-3584 CX Utrecht, Netherlands
关键词
D O I
10.1007/s00277-003-0685-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:654 / 659
页数:6
相关论文
共 33 条
[1]  
ALEXANIAN R, 1994, NEW ENGL J MED, V330, P484
[2]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[3]  
ATTAL MM, 2000, BLOOD, V101, pA2393
[4]   Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning [J].
Badros, A ;
Barlogie, B ;
Siegel, E ;
Cottler-Fox, M ;
Zangari, M ;
Fassas, A ;
Morris, C ;
Anaissie, E ;
Van Rhee, F ;
Tricot, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1295-1303
[5]   Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma [J].
Barlogie, B ;
Jagannath, S ;
Vesole, DH ;
Naucke, S ;
Cheson, B ;
Mattox, S ;
Bracy, D ;
Salmon, S ;
Jacobson, J ;
Crowley, J ;
Tricot, G .
BLOOD, 1997, 89 (03) :789-793
[6]   Total therapy with tandem transplants for newly diagnosed multiple myeloma [J].
Barlogie, B ;
Jagannath, S ;
Desikan, KR ;
Mattox, S ;
Vesole, D ;
Siegel, D ;
Tricot, G ;
Munshi, N ;
Fassas, A ;
Singhal, S ;
Mehta, J ;
Anaissie, E ;
Dhodapkar, D ;
Naucke, S ;
Cromer, J ;
Sawyer, J ;
Epstein, J ;
Spoon, D ;
Ayers, D ;
Cheson, B ;
Crowley, J .
BLOOD, 1999, 93 (01) :55-65
[7]   Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma:: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT) [J].
Björkstrand, B ;
Svensson, H ;
Goldschmidt, H ;
Ljungman, P ;
Apperley, J ;
Mandelli, F ;
Marcus, R ;
Boogaerts, M ;
Alegre, A ;
Remes, K ;
Cornelissen, JJ ;
Bladé, J ;
Lenhoff, S ;
Iriondo, A ;
Carlson, K ;
Volin, L ;
Littlewood, T ;
Goldstone, AH ;
San Miguel, J ;
Schattenberg, A ;
Gahrton, G .
BONE MARROW TRANSPLANTATION, 2001, 27 (05) :511-515
[8]   Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen [J].
Chakraverty, R ;
Peggs, K ;
Chopra, R ;
Milligan, DW ;
Kottaridis, PD ;
Verfuerth, S ;
Geary, J ;
Thuraisundaram, D ;
Branson, K ;
Chakrabarti, S ;
Mahendra, P ;
Craddock, C ;
Parker, A ;
Hunter, A ;
Hale, G ;
Waldmann, H ;
Williams, CD ;
Yong, K ;
Linch, DC ;
Goldstone, AH ;
Mackinnon, S .
BLOOD, 2002, 99 (03) :1071-1078
[9]   A randomized trial of maintenance interferon following a high-dose chemotherapy in multiple myeloma: long-term follow-up results [J].
Cunningham, D ;
Powles, R ;
Malpas, J ;
Raje, N ;
Milan, S ;
Viner, C ;
Montes, A ;
Hickish, T ;
Nicolson, M ;
Johnson, P ;
Treleaven, J ;
Raymond, J ;
Gore, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (02) :495-502
[10]   Interferon-α treatment in multiple myeloma:: Meta-analysis of 30 randomised trials among 3948 patients [J].
Fritz, E ;
Ludwig, H .
ANNALS OF ONCOLOGY, 2000, 11 (11) :1427-1436